Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
This may be related to the different intervention times for the included studies
This model eliminates wait times and gives Canadian patients the same treatment options available to Americans
Accessed May 6, 2023
Mounjaro is a dual-action drug (GLP-1 and GIP agonists)
The landmark SUSTAIN-6 trial , published in The New England Journal of Medicine , found that Semaglutide significantly reduced the risk of major adverse cardiovascular events (such as heart attack, stroke, or death from cardiovascular causes) in patients with type 2 diabetes who were at high cardiovascular risk
US$ 23.10
US$ 28.24
US$ 24.17
